Critical Care

official impact factor 4.60

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification

Pierre-François Laterre* and Xavier Wittebole

Critical Care 2003, 7:445-450 doi:10.1186/cc2342

Accesses  

  • Last 30 days: 53 accesses
  • Last 365 days: 768 accesses
  • All time: 11353 accesses